![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » UROPLASTY RECEIVES APPROVABLE LETTER FROM FDA FOR MACROPLASTIQUE IMPLANTS
UROPLASTY RECEIVES APPROVABLE LETTER FROM FDA FOR MACROPLASTIQUE IMPLANTS
September 14, 2006
Wednesday afternoon, Uroplasty, Inc., medical devices company, announced that it has received an approvable letter from FDA relating to its pre-market approval application for Macroplastique Implants for the treatment of female stress urinary incontinence. Trading Markets Live (http://www.tradingmarkets.com/.site/news/BREAKING%20NEWS/397759/)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct